
FDA clears new AI tool that can estimate risk of breast cancer recurrence
A newly FDA-cleared AI tool known as TumorSight Risk can estimate the chance of a patient's breast cancer coming back, and unlike many current tests, it can give this information before undergoing surgery.
ABC News' Rebecca Jarvis has the latest.
ABC News' Rebecca Jarvis has the latest.
ABC News
ABC News is your daily source for breaking national and world news, exclusive interviews and 24/7 live streaming coverage that will help you stay up to date on the events shaping our world. https://abcnews.go.com...